BioSpace News Archive

Researchers and graduate students receiving funding for projects in areas such as education, immigration, Indigenous health and the environment

Hematogenix®, a global leader in the field of cancer research and immuno-oncology testing, announces the availability of the assessment of B-cell maturation antigen (BCMA) by flow cytometry and immunohistochemistry (IHC) at its facilities globally.

While wishing to remain anonymous, a generous donor has provided $25 million to Children’s Hospital Los Angeles to support the expansion of the CHLA Neurological Institute and the hospital’s capacity in Interventional Radiology.

Epilepsy Foundation announced today it has elected three new board members who bring their professional expertise and personal epilepsy journeys to the Foundation’s already strong Board of Directors.

Statewide funding will support community-based initiatives making a difference beyond traditional care settings

Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that Leslie L. Dan has retired from the Company’s Board of Directors, effective July 16, 2019.

Exelixis, Inc. (NASDAQ: EXEL) announced today that its second quarter 2019 financial results will be released on Wednesday, July 31, 2019 after the markets close.

Catalent, Inc. (NYSE: CTLT) (“Catalent”), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, today announced that it will release financial results for the fourth quarter of fiscal year 2019 ended June 30, 2019, before the market open on Tuesday, August 27, 2019.

The CAP calls for the elimination of restrictions that prevent an open independent dispute resolution process

According to Coherent Market Insights, the global single use disposable patient positioning products market was valued at US$ 127.7 million in 2018, and is projected to exhibit a CAGR of 3.5% during the forecast period (2018 – 2026).